ScoreWhy is Rossari Biotech Ltd ?
1
Company has a Debt to Equity ratio (avg) of 0.07 times
2
Negative results in Mar 26
- OPERATING PROFIT TO INTEREST(Q) Lowest at 8.53 times
- DEBT-EQUITY RATIO(HY) Highest at 0.33 times
- INTEREST(Q) Highest at Rs 9.06 cr
3
With ROCE of 12.6, it has a Very Attractive valuation with a 2.1 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -15.56%, its profits have risen by 9.4% ; the PEG ratio of the company is 2.2
4
High Institutional Holdings at 20.38%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -15.56% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Rossari Biotech should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Rossari Biotech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Rossari Biotech
-15.46%
-0.45
34.56%
Sensex
-5.6%
-0.42
13.26%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
27.57%
EBIT Growth (5y)
15.39%
EBIT to Interest (avg)
9.37
Debt to EBITDA (avg)
0.60
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
1.55
Tax Ratio
26.32%
Dividend Payout Ratio
2.03%
Pledged Shares
0
Institutional Holding
20.38%
ROCE (avg)
16.27%
ROE (avg)
11.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
43
Price to Book Value
2.32
EV to EBIT
16.42
EV to EBITDA
11.88
EV to Capital Employed
2.07
EV to Sales
1.42
PEG Ratio
2.21
Dividend Yield
NA
ROCE (Latest)
12.59%
ROE (Latest)
11.19%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET SALES(Q)
Highest at Rs 684.86 cr
PBDIT(Q)
Highest at Rs 77.25 cr.
PAT(Q)
Highest at Rs 45.97 cr.
EPS(Q)
Highest at Rs 8.30
-13What is not working for the Company
OPERATING PROFIT TO INTEREST(Q)
Lowest at 8.53 times
DEBT-EQUITY RATIO(HY)
Highest at 0.33 times
INTEREST(Q)
Highest at Rs 9.06 cr
Loading Valuation Snapshot...
Here's what is working for Rossari Biotech
Net Sales - Quarterly
Highest at Rs 684.86 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 77.25 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 45.97 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 45.97 cr has Grown at 33.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 34.42 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 8.30
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Rossari Biotech
Operating Profit to Interest - Quarterly
Lowest at 8.53 times and Fallen
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Debt-Equity Ratio - Half Yearly
Highest at 0.33 times and Grown
each half year in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Interest - Quarterly
Highest at Rs 9.06 cr
in the last five quarters and Increased by 18.12 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Non Operating Income - Quarterly
Highest at Rs 19.07 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
